Skip to content

Clinical trials

Ocular Hypertension trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20071
20102
20141
20151
20191
20201
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
AbbVie2
Alcon Research1
EyeCool Therapeutics, Inc.1
Future Medicine1
Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)1
Novartis1
Pfizer1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
PolyActiva Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension14
Glaucoma, Open-Angle9
Glaucoma3
Eye Diseases1
Glaucoma, Angle-Closure1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.